Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
Titel:
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study
Auteur:
Schadendorf, D. Amonkar, M.M. Milhem, M. Grotzinger, K. Demidov, L.V. Rutkowski, P. Garbe, C. Dummer, R. Hassel, J.C. Wolter, P. Mohr, P. Trefzer, U. Lefeuvre-Plesse, C. Rutten, A. Steven, N. Ullenhag, G. Sherman, L. Wu, F.S. Patel, K. Casey, M. Robert, C.